调节性T细胞改善了血管素II诱导的心脏损伤
Heda Kvakan1, Markus Kleinewietfeld, Fatimunnisa Qadri
1Franz Volhard Clinic, HELIOS Clinic Berlin-Buch, Berlin, Germany.
Circulation
|May 28, 2009
概括
调节性T (Treg) 细胞可以防止高血压心脏损伤. 转移Treg细胞改善了小鼠的心脏结构和功能,独立于血压变化,提供了新的治疗途径.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 高血压病理生理学 高血压病理生理学
背景情况:
- 高血压通过目标器官损伤导致显著的发病率和死亡率,特别是心脏缩,心力衰竭和心律失常.
- ангиотензин II 是高血压的关键调解剂,促进炎症,导致心脏损伤.
- 免疫抑制调节T (Treg) 细胞在高血压心脏损伤中的作用在很大程度上仍未被探索.
研究的目的:
- 研究CD4+CD25+调节T (Treg) 细胞在血管素II诱导的高血压心脏损伤中的保护作用.
- 为了确定Treg细胞转移是否可以改善心脏缩,纤维化和高血压的小鼠模型中的电气重塑.
主要方法:
- 采用Treg细胞转移到注入血管新生素II以诱导高血压的小鼠中.
- 对心脏缩,纤维化和连接素43蛋白位址的评估.
- 对心脏组织中免疫细胞透的分析.
主要成果:
- 接受Treg细胞的患者表现出心脏缩和纤维化减少,尽管持续高血压.
- 心脏形态的改善与节律失常性电力改造的改善相关.
- 特雷格细胞转移使康涅素43间隙结蛋白位址正常化,并减少了炎症细胞透.
结论:
- 转移的Treg细胞具有免疫抑制作用,可以改善心脏损伤并改善电力重塑,独立于降低血压.
- 这些发现强调了Treg细胞在缓解高血压心脏损伤方面的关键作用.
- 这项研究提出了针对免疫系统调节的潜在新疗法策略,用于治疗高血压心脏损伤.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
01:25Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...